DOCETAXEL SPC 80 mg/4ml (20 mg/ml) Price

Overview

Welcome to Dwaey, specifically on DOCETAXEL SPC 80 mg/4ml (20 mg/ml) Concentrate for Solution for Infusion page.
This medicine contains an important and useful components, as it consists of Docetaxel.
DOCETAXEL SPC 80 mg/4ml (20 mg/ml) is available in the market in concentration 80 mg/4 ml and in the form of Concentrate for Solution for Infusion.

SUDAIR PHARMA COMPANY is the producer of DOCETAXEL SPC 80 mg/4ml (20 mg/ml) and it is imported from SAUDI ARABIA, The most popular alternatives of DOCETAXEL SPC 80 mg/4ml (20 mg/ml) are listed downward .

Mode Of Action

Docetaxel disrupts the microtubular network in cells that is essential for vital mitotic and interphase cellular functions. It binds to the free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly, resulting in inhibition of mitosis.

Indication

• Breast cancer
• Lung cancer
• Prostate cancer
• Stomach cancer
• Head/neck cancer

Precaution

Lactation. Hepatic impairment. Monitor liver blood function and blood counts regularly. Premedication with oral dexamethsaone at 16 mg daily for 3 days, starting one day before docetaxel treatment is recommended. Lactation: Not known if excreted in breast milk, do not nurse

Side Effects

• >50% Alopecia
• Anemia
• Leukopenia
• Neutropenia
• Asthenia 10-50% Fever
• Infections
• Fluid retention
• Hypersensitivity
• Skin reactions
• Diarrhea
• Nausea
• Vomiting
• Sensory neuropathy
• Myalgia
• Nail changes 1-10% Arthralgia
• Thrombocytopenia Potentially Fatal: Neutropenia; fluid retention syndrome; anaemia.

Contra indication

Previous severe hypersensitivity reaction to docetaxel, the solvent or polysorbate 80. Severe neutropenia; pregnancy, severe liver impairment.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.